Most studies evaluating risk for future suicide attempts in major depressive disorder (MDD) have methodologic limitations, e.g., no structured diagnostic interviews or restricted to one or other domain of potential predictors. However, determinants of suicidal behavior are derived from multiple domains including psychopathologic, neurobiological, neurocognitive, familial and psychosocial. As such, development of predictive or explanatory models of suicide attempt behavior requires assessment of potential risk factors from multiple domains in the same patient population in a prospective follow-up study. This prospective study of suicidal behavior in major depression utilizes a unique cohort of patients undergoing a baseline evaluation for MDD, comprising two comparable groups of past attempters and nonattempters. Patients receive extensive clinical and biological baseline assessments funded by the MH062185 Conte Center for the Neuroscience of Mental Disorders at NYSPI/Columbia University. This application provides funding to assess patients for clinical state, life events, treatment and suicidal behavior at 3, 12 and 24 months after discharge. The initial major emphasis had been to build a clinical predictive model and begin testing that model. In the current funding period, the utility of biological predictors was assessed. Promising results identify stress reactivity, neurocognitive indices, and PET quantification of the serotonin system as potential risk factors that principally target traits underlying the diathesis for suicidal behavior. The current application shifts the emphasis to an integration of these biological and neurocognitive predictors with previously identified clinical predictors into a explanatory AND predictive model of suicidal behavior. To that end, the application adds an evaluation of early childhood trauma, neurocognitive tests (decision-making and problem solving) and stress reactivity (Trier Social Stress Test) measures, to complement PET scans and clinical measures obtained in the Conte Center at baseline. Statistical model building methods and prediction strategies will construct optimal models with both heuristic and clinical value.
Most studies evaluating predictors of suicide attempts in major depressive disorder have methodologic limitations, e.g., no structured diagnostic interviews, restricted to one or other domain of potential predictor variables or chart reviews to quantify suicidal behavior. We have implemented the most comprehensive, neurobiological, neurocognitve and clinical prospective study of predictors of suicidal behavior in major depression. We will test behavioral predictors of suicide attempts from the following assessment in multiple domains: 1) stress responsiveness;2) PET quantification of the serotonin transporter and 5-HT1A receptor;and 3) neurocognitive measures. This data will permit construction of predictive and explanatory models for suicidal behavior.
|Ganança, Licinia; Galfalvy, Hanga C; Oquendo, Maria A et al. (2017) Lipid correlates of antidepressant response to omega-3 polyunsaturated fatty acid supplementation: A pilot study. Prostaglandins Leukot Essent Fatty Acids 119:38-44|
|Coleman, Daniel; Lawrence, Ryan; Parekh, Amrita et al. (2017) Narcissistic Personality Disorder and suicidal behavior in mood disorders. J Psychiatr Res 85:24-28|
|Chhetry, Binod Thapa; Hezghia, Adrienne; Miller, Jeffrey M et al. (2016) Omega-3 polyunsaturated fatty acid supplementation and white matter changes in major depression. J Psychiatr Res 75:65-74|
|Lawrence, Ryan E; Brent, David; Mann, J John et al. (2016) Religion as a Risk Factor for Suicide Attempt and Suicide Ideation Among Depressed Patients. J Nerv Ment Dis 204:845-850|
|Chaudhury, Sadia R; Singh, Tanya; Burke, Ainsley et al. (2016) Clinical Correlates of Planned and Unplanned Suicide Attempts. J Nerv Ment Dis 204:806-811|
|Oquendo, Maria A; Galfalvy, Hanga; Sullivan, Gregory M et al. (2016) Positron Emission Tomographic Imaging of the Serotonergic System and Prediction of Risk and Lethality of Future Suicidal Behavior. JAMA Psychiatry 73:1048-1055|
|Sublette, M Elizabeth; Vaquero, Concepcion; Baca-Garcia, Enrique et al. (2016) Lack of association of SNPs from the FADS1-FADS2 gene cluster with major depression or suicidal behavior. Psychiatr Genet 26:81-6|
|Dervic, K; Garcia-Amador, M; Sudol, K et al. (2015) Bipolar I and II versus unipolar depression: clinical differences and impulsivity/aggression traits. Eur Psychiatry 30:106-13|
|Gorlyn, Marianne; Keilp, John; Burke, Ainsley et al. (2015) Treatment-related improvement in neuropsychological functioning in suicidal depressed patients: paroxetine vs. bupropion. Psychiatry Res 225:407-12|
|Sher, Leo; Grunebaum, Michael F; Sullivan, Gregory M et al. (2014) Association of testosterone levels and future suicide attempts in females with bipolar disorder. J Affect Disord 166:98-102|
Showing the most recent 10 out of 137 publications